Atossa Therapeutics, Inc. (BMV:ATOS)

Atossa Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	57.86	71.08	88.46	110.89	136.38	39.55
Cash & Short-Term Investments	57.86	71.08	88.46	110.89	136.38	39.55
Cash Growth	-27.25%	-19.64%	-20.23%	-18.69%	244.79%	214.39%
Other Receivables	-	-	-	0.74	1.07	0.64
Total Trade Receivables	-	-	-	0.74	1.07	0.64
Other Current Assets	4.66	3.37	3.76	6.56	3.79	2.58
Total Current Assets	62.52	74.46	92.22	118.2	141.24	42.77
Net Property, Plant & Equipment	-	-	-	-	-	0.04
Other Intangible Assets	-	-	-	-	-	0.01
Long-Term Investments	-	-	1.71	4.7	-	-
Other Long-Term Assets	2	1.99	2.32	0.64	0.02	0.02
Total Assets	64.52	76.44	96.25	123.53	141.26	42.84
Accounts Payable	2.01	0.68	0.81	2.97	1.72	1.59
Accrued Expenses	3.25	2.78	2.63	2.58	1.39	1.06
Current Portion of Leases	-	-	-	-	-	0.02
Other Current Liabilities	1.56	1.51	1.8	0.02	0.02	13.01
Total Current Liabilities	6.82	4.97	5.24	5.57	3.13	15.67
Total Liabilities	6.82	4.97	5.24	5.57	3.13	15.67
Common Stock	23.49	23.49	22.79	22.79	22.79	8.56
Treasury Stock	-1.48	-1.48	-1.48	-	-	-
Additional Paid-in Capital	262.62	261.26	255.99	251.37	244.58	130.51
Retained Earnings	-226.93	-211.79	-186.29	-156.19	-129.23	-111.9
Shareholders' Equity	57.7	71.48	91.02	117.96	138.14	27.17
Total Liabilities & Equity	64.52	76.44	96.25	123.53	141.26	42.84
Total Debt	0	0	0	0	0	0.02
Net Cash (Debt)	57.86	71.08	88.46	110.89	136.38	39.54
Net Cash Growth	-18.61%	-19.64%	-20.23%	-18.69%	244.94%	215.51%
Net Cash Per Share	0.45	0.56	0.70	0.88	1.17	3.50
Book Value	57.7	71.48	91.02	117.96	138.14	27.17
Book Value Per Share	0.45	0.57	0.72	0.93	1.18	2.40
Tangible Book Value	57.7	71.48	91.02	117.96	138.14	27.16
Tangible Book Value Per Share	0.45	0.57	0.72	0.93	1.18	2.40

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.